CDK5 and cervical cancer: In addition, small molecules like PHA-767491 and PHA793887 were reported to inhibit the activity of CDK5 by occupying the ATP binding sites of CDK5, exerting an anticancer effect on cervical cancer and breast cancer [101–104].